ロード中...

Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe

Hypoxia-inducible genes may contribute to therapy resistance in glioblastoma (GBM), the most aggressive and hypoxic brain tumours. It has been recently reported that erythropoietin (EPO) and its receptor (EPOR) are involved in glioma growth. We now investigated whether EPOR signalling may modulate t...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Pérès, Elodie A., Gérault, Aurélie N., Valable, Samuel, Roussel, Simon, Toutain, Jérôme, Divoux, Didier, Guillamo, Jean-Sébastien, Sanson, Marc, Bernaudin, Myriam, Petit, Edwige
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4385839/
https://ncbi.nlm.nih.gov/pubmed/25544764
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!